BF Biosciences gains DRAP's approval for brownfield expansion

MG News | September 09, 2024 at 11:49 AM GMT+05:00

Add Mettisglobal as a Trusted Source on Google

0:00

September 09, 2024 (MLN): BF Biosciences Limited, a subsidiary of Ferozsons Laboratories Limited (PSX: FEROZ), has secured approval from the Drug Regulatory Authority of Pakistan (DRAP) for its brownfield expansion (Line II).

This expansion includes a pre-filled syringes line, a liquid and lyophilized line, and a product development section.

The commercial production from the pre-filled syringes line has commenced, whereas the liquid & lyophilized line is under internal validation and will start commercial production in the second quarter of FY 2024-25.

Additionally, BF Biosciences Limited has launched Sematide (Semaglutide) in a pre-filled syringe.

Sematide is the first Glucagon-Like Peptide 1 (GLP1) receptor agonist approved for local manufacture in Pakistan, offering a convenient solution for diabetes management.

The pre-filled syringe eliminates dosing errors and is easy to use by the patients.

Sematide is being manufactured at the new state-of-the-art European prefilled syringes line of BF Biosciences Limited.

Copyright Mettis Link News

Related News

Name	Price/Vol	%Chg/NChg
KSE100	177,623.88 478.02M	-0.36% -638.45
ALLSHR	107,472.27 954.45M	-0.34% -365.17
KSE30	53,131.56 115.62M	-0.41% -216.11
KMI30	250,814.93 150.64M	-0.28% -695.43
KMIALLSHR	68,971.49 608.41M	-0.29% -202.37
BKTi	50,769.48 23.80M	-0.58% -295.25
OGTi	34,999.12 6.26M	-0.71% -249.30

Symbol	Bid/Ask	High/Low

Name	Last	High/Low	Chg/%Chg
BITCOIN FUTURES	63,405.00	64,810.00 63,035.00	-1560.00 -2.40%
BRENT CRUDE	86.90	88.06 84.70	-1.46 -1.65%
RICHARDS BAY COAL MONTHLY	105.75	0.00 0.00	-1.55 -1.44%
ROTTERDAM COAL MONTHLY	120.00	0.00 0.00	0.25 0.21%
USD RBD PALM OLEIN	1,175.00	1,175.00 1,175.00	0.00 0.00%
CRUDE OIL - WTI	81.43	82.43 79.80	-1.18 -1.43%
SUGAR #11 WORLD	14.52	14.70 14.51	-0.06 -0.41%